EDAP TMS
EDAP
About: Edap TMS SA is a holding company operating in three divisions namely, HIFU (High-Intensity Focused Ultrasound), ESWL (Extracorporeal ShockWave Lithotripsy), and Distribution. The HIFU division develops, manufactures, and markets devices for the invasive destruction of certain types of tumors using HIFU technology. It markets three HIFU devices: the Ablatherm, Ablatherm Fusion, and the Focal One. The ESWL division is engaged in the manufacturing, marketing, and servicing of its installed base of Sonolith range of lithotripters. The Distribution division markets products that are complementary to its globalized activity such as lasers, micro-ultrasound systems, and other medical products from third parties. Its geographical segments are Asia, France, United States, and Others.
Employees: 310
Fund manager confidence
Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)
300% more call options, than puts
Call options by funds: $160K | Put options by funds: $40K
40% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 5
6% more funds holding
Funds holding: 33 [Q1] → 35 (+2) [Q2]
1.92% less ownership
Funds ownership: 39.38% [Q1] → 37.46% (-1.92%) [Q2]
19% less capital invested
Capital invested by funds: $28.6M [Q1] → $23.1M (-$5.53M) [Q2]
60% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 5
Financial journalist opinion
Based on 5 articles about EDAP published over the past 30 days
